Acusphere, Inc.
Pharmaceutical firm spends $8.4M to build out facility for drug manufacturing
Published in Lab Business Week, September 18th, 2005
As of June 30, 2005, the company's balance of cash and cash equivalents totaled $60.2 million. During Q2, the company spent $13.3 million on investing activities, $8.4 million of which spending was incurred for the build-out the company's commercial manufacturing facility for AI-700.
The company's estimate of its total 2005 capital expenditures is unchanged from its Q1 report. Approximately $11.7 million and $3.2 million remaining to be paid for the manufacturing facility build-out and for equipment purchases, respectively,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-09-18)
More Articles from Lab Business Week
- Access Pharmaceuticals, Inc.
Pharmaceutical company announces financing arrangement - Actavis
Pharma company appoints chief executive of finance - Adherex Technologies, Inc.
Pharmaceutical firm reports loss of $0.13 per share - Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm posts loss of $0.06 per share - Alder Biopharmaceuticals, Inc.
Biopharmaceutical company raises $11.1M in series A financing - Allos Therapeutics, Inc.
Biopharmaceutical firm reports loss of $0.13 per share - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
